welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
- log in
Nicolas S. Wein, PhD
Center for Gene Therapy
Abigail Wexner Research Institute
700 Children's Drive
Columbus, Ohio, United States
Dr. Nicolas S. Wein is a Principal Investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute. Dr. Wein received his PhD in Molecular Biology in the laboratory of Nicolas Levy, MD, PhD, at the Marseille Medical School in France, where he worked on the development of new diagnosis tools for neuromuscular diseases, the discovery of the Minidysferline and its use for gene transfer, and investigation of the use of exon-skipping for dysferlinopathies.
In 2011, he joined the team of Kevin Flanigan, MD, Principal Investigator in The Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital, as a Postdoctoral Scientist. Dr. Wein worked on the identification of novel IRES in the dystrophin gene and on an out-of-frame exon-skipping approach that can benefit patients with 5’ mutations in the DMD gene.
Pfizer Says No New Serious Adverse Events in DMD Gene Therapy TrialDrugmaker Pfizer Inc said on Tuesday tha...
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapyDuchenne muscular dystrophy (DMD) is a p...
Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and MesoangioblastsDuchenne muscular dystrophy (DMD) is a l...
From Flask to Vat: The Challenges of Scaling Up Gene TherapyOver the past two decades, gene therapy ...
Gene Therapy OverviewIn this brief document, we want to expla...
How AAV Gene Transfer Works – General Audiencehttps://youtu.be/SUOskEqLpyY...
Personalized gene and cell therapy for Duchenne Muscular DystrophyDystrophinopathies are diseases caused b...